MedTrace Logo

Oral Progestogen Supplementation in the Prevention of Recurrent Uterine Contraction in Preterm Labor

NCT02262481 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2016-01-28

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of oral progesterone supplementation in preterm labor on the prevention of recurrent uterine contraction and prolonging pregnancy period, and its side effect.

Conditions

  • Preterm Labor

Interventions

DRUG

dydrogesterone

DRUG

placebo

Sponsors & Collaborators

  • Chulalongkorn University

    lead OTHER

Principal Investigators

  • Vorapong Phupong, M.D. · Chulalongkorn University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02262481 on ClinicalTrials.gov